FRG Family Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.77M | Sell |
7,680
-144
| -2% | -$78.1K | 0.62% | 41 |
|
|
2025
Q4 | $4.53M | Sell |
7,824
-117
| -1% | -$66.2K | 0.7% | 35 |
|
|
2025
Q3 | $3.85M | Sell |
7,941
-380
| -5% | -$177K | 0.62% | 41 |
|
|
2025
Q2 | $3.37M | Sell |
8,321
-220
| -3% | -$92K | 0.59% | 36 |
|
|
2025
Q1 | $4.25M | Sell |
8,541
-435
| -5% | -$236K | 0.82% | 31 |
|
|
2024
Q4 | $4.67M | Sell |
8,976
-1,700
| -16% | -$935K | 0.85% | 30 |
|
|
2024
Q3 | $6.6M | Hold |
10,676
| – | – | 1.18% | 21 |
|
|
2024
Q2 | $6.43M | Sell |
10,676
-5
| -0% | -$2.86K | 1.24% | 21 |
|
|
2024
Q1 | $6.07M | Sell |
10,681
-178
| -2% | -$99.9K | 1.19% | 23 |
|
|
2023
Q4 | $5.76M | Hold |
10,859
| – | – | 1.17% | 24 |
|
|
2023
Q3 | $5.5M | Buy |
10,859
+375
| +4% | +$200K | 1.24% | 23 |
|
|
2023
Q2 | $5.47M | Sell |
10,484
-64
| -0.6% | -$34.5K | 1.2% | 24 |
|
|
2023
Q1 | $6.08M | Sell |
10,548
-400
| -4% | -$225K | 1.39% | 24 |
|
|
2022
Q4 | $6.03M | Sell |
10,948
-775
| -7% | -$411K | 1.44% | 22 |
|
|
2022
Q3 | $5.95M | Sell |
11,723
-274
| -2% | -$153K | 1.47% | 20 |
|
|
2022
Q2 | $6.52M | Sell |
11,997
-85
| -0.7% | -$46.8K | 1.51% | 17 |
|
|
2022
Q1 | $7.14M | Buy |
12,082
+55
| +0.5% | +$31.6K | 1.39% | 20 |
|
|
2021
Q4 | $8.03M | Sell |
12,027
-455
| -4% | -$284K | 1.5% | 17 |
|
|
2021
Q3 | $7.13M | Sell |
12,482
-600
| -5% | -$329K | 1.4% | 18 |
|
|
2021
Q2 | $6.6M | Buy |
13,082
+393
| +3% | +$185K | 1.25% | 23 |
|
|
2021
Q1 | $5.79M | Sell |
12,689
-333
| -3% | -$159K | 1.18% | 26 |
|
|
2020
Q4 | $6.07M | Hold |
13,022
| – | – | 1.32% | 22 |
|
|
2020
Q3 | $5.75M | Sell |
13,022
-245
| -2% | -$101K | 1.4% | 22 |
|
|
2020
Q2 | $4.81M | Hold |
13,267
| – | – | 1.27% | 24 |
|
|
2020
Q1 | $3.76M | Sell |
13,267
-132
| -1% | -$41.6K | 1.14% | 28 |
|
|
2019
Q4 | $4.35M | Sell |
13,399
-1,080
| -7% | -$327K | 1.05% | 29 |
|
|
2019
Q3 | $4.22M | Hold |
14,479
| – | – | 1.09% | 28 |
|
|
2019
Q2 | $4.25M | Buy |
14,479
+435
| +3% | +$120K | 1.12% | 29 |
|
|
2019
Q1 | $3.84M | Buy |
14,044
+30
| +0.2% | +$7.47K | 1.09% | 29 |
|
|
2018
Q4 | $3.14M | Buy |
14,014
+1,230
| +10% | +$289K | 1.03% | 30 |
|
|
2018
Q3 | $3.12M | Buy |
12,784
+1,865
| +17% | +$429K | 0.86% | 37 |
|
|
2018
Q2 | $2.26M | Buy |
10,919
+734
| +7% | +$156K | 0.68% | 47 |
|
|
2018
Q1 | $2.1M | Sell |
10,185
-185
| -2% | -$38.8K | 0.7% | 50 |
|
|
2017
Q4 | $1.97M | Sell |
10,370
-22
| -0.2% | -$4.21K | 0.64% | 51 |
|
|
2017
Q3 | $1.97M | Sell |
10,392
-200
| -2% | -$36.2K | 0.68% | 51 |
|
|
2017
Q2 | $1.85M | Buy |
10,592
+427
| +4% | +$71.7K | 0.68% | 52 |
|
|
2017
Q1 | $1.56M | Sell |
10,165
-340
| -3% | -$52K | 0.61% | 54 |
|
|
2016
Q4 | $1.48M | Hold |
10,505
| – | – | 0.62% | 53 |
|
|
2016
Q3 | $1.67M | Hold |
10,505
| – | – | 0.75% | 48 |
|
|
2016
Q2 | $1.55M | Hold |
10,505
| – | – | 0.7% | 48 |
|
|
2016
Q1 | $1.48M | Hold |
10,505
| – | – | 0.72% | 49 |
|
|
2015
Q4 | $1.49M | Buy |
+10,505
| New | +$1.4M | 0.73% | 50 |
|
Other funds holding TMO
VCM
FRG Family Wealth Advisors's TMO Position: Q1 2026 in Review
FRG Family Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q1 2026, selling an estimated $78.1K and leaving 7,680 shares worth $3.77M. The position accounts for 0.62% of the portfolio, ranked #41.
FRG Family Wealth Advisors first reported a position in TMO in Q4 2015 and has held it in 42 quarters since. The position peaked at $8.03M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- FRG Family Wealth Advisors held 7,680 shares of Thermo Fisher Scientific worth $3.77M as of Q1 2026.
- FRG Family Wealth Advisors sold 144 Thermo Fisher Scientific shares in Q1 2026, an estimated $78.1K.
- Thermo Fisher Scientific made up 0.62% of FRG Family Wealth Advisors's portfolio in Q1 2026, its #41 holding.
- FRG Family Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 42 quarters since.
- FRG Family Wealth Advisors's Thermo Fisher Scientific position peaked at $8.03M in Q4 2021.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on FRG Family Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.